Nature Immunology ( IF 27.7 ) Pub Date : 2024-09-17 , DOI: 10.1038/s41590-024-01961-3 Sarah A Weiss 1, 2, 3, 4 , Amy Y Huang 1, 2, 3, 5 , Megan E Fung 1, 2 , Daniela Martinez 3, 6, 7, 8 , Alex C Y Chen 3, 6, 7, 8 , Thomas J LaSalle 3, 6, 7, 8 , Brian C Miller 9, 10, 11, 12 , Christopher D Scharer 13 , Mudra Hegde 3 , Thao H Nguyen 1, 2 , Jared H Rowe 1, 2, 14 , Jossef F Osborn 1, 2 , Dillon G Patterson 1, 2 , Natalia Sifnugel 1, 2 , C Mei-An Nolan 1, 2 , Richard A Davidson 6 , Marc A Schwartz 3, 6 , Alexander P R Bally 13 , Dennis K Neeld 13 , Martin W LaFleur 1, 2 , Jeremy M Boss 13 , John G Doench 3 , W Nicholas Haining 3, 14, 15 , Arlene H Sharpe 1, 2, 3, 16 , Debattama R Sen 3, 6, 7, 8
PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8+ T cells in chronic infection, creating a ‘sweet spot’ of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1-knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8+ T cell dysfunction while avoiding excess immunopathology.
中文翻译:
PD-1 表达的表观遗传调节可改善耗竭的 T 细胞功能和病毒控制
PD-1 是 CD8+ T 细胞活化的关键负调节因子,在癌症和慢性病毒感染中由耗竭的 T 细胞高度表达。尽管 PD-1 阻断可以改善病毒和肿瘤控制,但生理性 PD-1 表达可防止免疫病理学并改善记忆形成。在耗竭中驱动 PD-1 高表达的机制尚不清楚,对于理清其有益和有害的影响可能至关重要。在这里,我们使用删除耗竭特异性 PD-1 增强子的小鼠模型对 PD-1 的表观遗传调控进行了功能研究。在慢性感染中,增强子缺失仅改变 CD8+ T 细胞中的 PD-1 表达,从而产生中间表达的“最佳位置”,与野生型和 Pdcd1 敲除细胞相比,T 细胞功能得到优化。这允许在没有额外免疫病理学的情况下改善对慢性感染的控制。总之,这些结果表明,通过表观遗传编辑调整 PD-1 可以减少 CD8+ T 细胞功能障碍,同时避免过度免疫病理学。